LivaNova PLC
LIVN: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$16.00 | Dqqxnrw | Ctm |
LivaNova Earnings: Competitor's Oxygenator Woes Fuel Strong Revenue Growth
Narrow-moat LivaNova reported robust third-quarter results that ran slightly ahead of our expectations on the top line, but our slight adjustments to our near-term estimates weren’t enough to materially shift our fair value estimate. The shares remain fairly valued, in our view.